Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer’s disease

Zhang, Zhentao, Obianyo, Obiamaka, Dall, Elfriede, Du, Yuhong, Fu, Haian, Liu, Xia, Kang, Seong Su, Song, Mingke +7 more·2017·Nature Communications
DOI 10.1038/ncomms14740

Cited by (149)

Items 101–149 of 149

  1. Association between atherosclerosis and the development of multi-organ pathologies
    Siarhei A. Dabravolski, Alexey Viktorovich Churov, Natalia Vladimirovna Elizova, Alessio L. Ravani, Amina E Karimova, Vasily N. Sukhorukov, Alexander Nikolaevich Orekhov · 2024 · SAGE Open Medicine
  2. Asparagine endopeptidase cleaves apolipoprotein A1 and accelerates pathogenesis of atherosclerosis
    Mengmeng Wang, Bowei Li, Shuke Nie, Xin Meng, Guangxing Wang, Menghan Yang, Wenxin Dang, Kangning He, Tucheng Sun, Ping Xu et al. · 2025 · Journal of Clinical Investigation
  3. Intraneuronal Aβ accumulation causes tau hyperphosphorylation via endolysosomal leakage
    Yang Gao, Lisha Wang, Tosca Doeswijk, Bengt G. Winblad, Sophia Schedin‐Weiss, Lars O. Tjernberg · 2025 · Alzheimer s & Dementia
  4. Lack of association between LGMN and Alzheimer’s disease in the Southern Han Chinese population
    Xinyue Zhang, Bin Jiao, Ling Weng, Yafang Zhou, Lina Guo, Xin Wang, Lu Zhou, Xixi Liu, Xuewen Xiao, Hui Liu et al. · 2020 · European Journal of Neuroscience
  5. Advances in Alzheimer’s disease: mechanistic insights and therapeutic targets
    Yu-Juan Jia, Yi‐Jun Ge, Bowei Li, Ying Yang, Huaqiu Chen, Jie Liu, Junhong Guo, Jin‐Tai Yu, Keqiang Ye, Jian‐Zhi Wang et al. · 2026 · Science China Life Sciences
  6. Conception, Synthesis and In silico Assessment of New Morpholine-Containing Compounds Against Human Legumain and Cholinesterase Enzymes
    Abderrahmen Abdelli, Sarra Ouni, Hédi M’rabet, Mohamed Lotfi Efrit, Damien Prim · 2023 · Chemistry Africa
  7. The Amyloid Precursor Protein: More than Just Amyloid- Beta
    Stefan D. Jevtic, John Provias · 2019 · Journal of Neurology and Experimental Neuroscience
  8. Modular synthesis of 2,4-diaminoanilines as CNS drug-like non-covalent inhibitors of asparagine endopeptidase
    Lorenzo Calugi, Elena Lenci, Francesca Bianchini, Alessandro Contini, Andrea Trabocchi · 2022 · Bioorganic & Medicinal Chemistry
  9. Legumain/asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment
    Daisuke Taniguchi, Shotaro Shimonaka, Imtiaz Ahmed, Montasir Elahi, Taku Hatano, Yuzuru Imai, Nobutaka Hattori · 2024 · Neurobiology of Disease
  10. Structure-based computer-aided drug design to identify potential lead molecules for Asparaginyl Endopeptidase inhibitors
    Meenakshi Singh, Ian Steinke, Rajesh Amin · 2024 · Journal of Biomolecular Structure and Dynamics
  11. Employing complementary fractionation‐based N‐terminomics approaches enhances the identification of legumain cleavage events in naïve and inflamed colon tissue
    Alexander R. Ziegler, Benjamin L. Parker, Nichollas E. Scott, Laura E. Edgington‐Mitchell · 2025 · Protein Science
  12. Alzheimer’s Disease: From Pathogenesis to Emerging Therapeutic Targets
    Tetsuya Takahashi, Kazuki Muguruma · 2026 · Journal of Clinical Medicine
  13. Legumain Functions as a Transient TrkB Sheddase
    Christoph Holzner, Katharina Böttinger, Constantin Blöchl, Christian G. Huber, Sven O. Dahms, Elfriede Dall, Hans Brandstetter · 2023 · International Journal of Molecular Sciences
  14. FAM49B Fragmentation by Asparagine Endopeptidase Promotes Vascular Smooth Muscle Cell Migration in Atherogenesis
    Xuying Xiang, Mengting Qin, Lei Nie, Xiaoqing Guo, Jiaojiao Chen, Dailiang Jiang, Zhentao Zhang, Ling Mao · 2025 · Arteriosclerosis Thrombosis and Vascular Biology
  15. Monocyte-Derived LGMN + Macrophages Divert Lung Injury Outcomes toward Fibrosis through Matrix Remodeling
    Zhongzheng Li, Y H Zhang, Kun Yang, Diwen Zheng, Yulong Chen, Yuqing Zhang, Xin Pan, Peishuo Yan, Ivan O. Rosas, Guoying Yu et al. · 2026 · Research
  16. Structural and functional studies of legumain–mycocypin complexes revealed a competitive, exosite-regulated mode of interaction
    Tasneem Elamin, Naiá P. Santos, Peter Briza, Hans Brandstetter, Elfriede Dall · 2022 · Journal of Biological Chemistry
  17. Aronia juice improves working memory and suppresses δ-secretase activity in 5XFAD mice
    Takuya Yamane, Momoko Imai, Satoshi Handa, Hideo Ihara, Tatsuji Sakamoto, Tetsuo Ishida, Takenori Nakagaki, Susumu Uchiyama · 2023 · NFS Journal
  18. A non-peptide-based fluorescent probe capable of sensitively visualizing asparagine endopeptidase
    Kang Li, Yanxian Hou, Jinliang Han, Chengyuan Lv, Wenkai Liu, Jianjun Du, Wen Ce Sun, Jiangli Fan, Xiaojun Peng · 2024 · Chemical Communications
  19. Noncovalent interactions involving metals: The emerging roles of spodium, matere, and coinage bonds
    Rosa M. Gomila, Antonio Frontera · 2025 · Advances in inorganic chemistry
  20. Enzymatic Targets for Drug Discovery Against Alzheimer's Disease
    Ahmet Ozan ÖZGEN, Ozan Emre Eyüpoğlu · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
  21. Asparagine endopeptidase (AEP) inhibitor formulation via zein-based nanoparticle improves the therapeutic efficacy toward Alzheimer's disease
    Xin Meng, Mengmeng Wang, Menghan Yang, Guangxing Wang, Zhenlei Zhao, Zhongyun Xie, Bowei Li, Zhengjiang Qian, Seong Su Kang, Wenhua Zheng et al. · 2025 · Neurotherapeutics
  22. Relationship between Rad23 Overexpression and Tau NFT Buildup in Alzheimer’s Disease
    Roy Rao · 2023 · International Journal of Clinical and Experimental Medicine Research
  23. Roles of C/EBPβ/AEP in Neurodegenerative Diseases
    Jing Guo, Xinyi Liu, Sha-Sha Yang, Qiang Li, Yang Duan, Shanshan Zhu, Ke Zhou, Yi-Zhi Yan, Peng Hui Zeng · 2025 · Current Topics in Medicinal Chemistry
  24. Treatments with the specific δ‐secretase inhibitor, compound 11, promote the regeneration of motor and sensory axons after peripheral nerve injury
    Robin H. Isaacson, Darío I. Carrasco, Hannah Holliday, Seong Su Kang, Samia Khan, David Kim, Xia Liu, Keqiang Ye, ARTHUR WM. ENGLISH · 2023 · European Journal of Neuroscience
  25. FAIMS-enabled N-terminomics analysis reveals novel legumain substrates in murine spleen
    Alexander R. Ziegler, Antoine Dufour, Nichollas E. Scott, Laura E. Edgington‐Mitchell · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  26. AE-PocketMiner Uses Attention to Simultaneously Predict Cryptic Pockets and Their Allosteric Coupling
    Si Zhang, Prajna Mishra, Devin G. Kelly, Rachit Kumar, Gregory R. Bowman · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  27. The Norepinephrine Metabolite DOPEGAL Confers Locus Coeruleus Tau Vulnerability and Propagation via Asparagine Endopeptidase
    Seong Su Kang, Xia Liu, Eun Hee Ahn, Jie Xiang, Fredric P. Manfredsson, Xifei Yang, Hongbo Robert Luo, Larry Cameron Liles, David Weinshenker, Keqiang Ye · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  28. Когнітивна дисфункція в дітей: можливості фармакологічної корекції із застосуванням комплексу амінокислот та вітаміну В6
    Микола Валентинович Хайтович · 2019 · INTERNATIONAL NEUROLOGICAL JOURNAL
  29. Data from C/EBPβ/AEP Signaling Regulates the Oxidative Stress in Malignant Cancers, Stimulating the Metastasis
    Kecheng Lei, Seong Su Kang, Eun Hee Ahn, Chun Chen, Jianming Liao, Xia Liu, Hua Li, Laura E. Edgington‐Mitchell, Lingjing Jin, Keqiang Ye · 2023
  30. How Alzheimer’s Aβ propagates and triggers tau pathology in intact neurons
    Tomoya Sasahara, Shoko Hongo, Mika Ito, Naomi Takino, Shin‐ichi Muramatsu, Akiyoshi Kakita, Minako M. Hoshi · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Conformational and Functional Regulation of SET by Legumain Cleavage
    Carina Horak, Alexander C. Wieland, Rupert Klaushofer, Peter Briza, Hans Brandstetter, Elfriede Dall · 2025 · Journal of Molecular Biology
  32. Protocol for the recombinant expression and purification of the LSAM domain of human legumain in E. coli
    Sven O. Dahms, Alexander C. Wieland, Hans Brandstetter, Elfriede Dall · 2025 · STAR Protocols
  33. Positional scanning and computational modeling reveal determinants of legumain transpeptidase activity
    Rupert Klaushofer, Sven O. Dahms, Hans Brandstetter, Elfriede Dall · 2026 · Protein Science
  34. Additional file 1 of A novel transgenic mouse line with hippocampus-dominant and inducible expression of truncated human tau
    Gao, Yang, Wang, Yuying, Lei, Huiyang, Xu, Zhendong, Li, Shihong, Yu, Haitao, Jiazhao Xie, Zhang, Zhentao, Liu, Gongping, Zhang, Yao et al. · 2023 · Figshare
  35. Additional file 1 of Heat-related illness and dementia: a study integrating epidemiological and experimental evidence
    Kuo, Wan-Yin, Huang, Chien-Cheng, Chen, Chi-An, Ho, Chung-Han, Tang, Ling‑Yu, Lin, Hung-Jung, Su, Shih-Bin, Wang, Jhi-Joung, Hsu, Chien-Chin, Chang, Ching-Ping et al. · 2024 · Figshare
  36. Additional file 1 of Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer’s disease
    Wang, Shan-Shan, Liu, Zi-Kai, Liu, Jing-Jing, Cheng, Qing, Wang, Yan-Xia, Liu, Yan, Ni, Wen-Wen, Hongzhuan CHEN, Song, Mingke · 2021 · Figshare
  37. Molecular mechanisms of action of MT-MMPs involved in the pathogenesis of Alzheimer’s disease
    Laura García‐González · 2020 · theses.fr (ABES)
  38. Métalloprotéases matricielles et maladie d'Alzheimer : étude des rôles de MT1- et MT5-MMP dans l'amyloïdogenèse et la neuro-inflammation
    Jean‐Michel Paumier · 2018 · theses.fr (ABES)
  39. MT5-MMP promotes neuroinflammation, pathogenic processing of amyloid precursor protein and synaptic dysfunction at early stages in an Alzheimer's disease model
    Dominika Piłat · 2021 · theses.fr (ABES)
  40. Anti‐Aging Protein Klotho Attenuates Schizophrenia‐Associated Cognitive and Synaptic Dysfunctions by Regulating GluN2B‐NMDARs in the Hippocampus
    Jin‐Qiong Zhan, Yi‐Heng Li, Fu-hao Jiang, Huan Wang, Yang Huang, Hai-Yan Zhan, Xiao‐Mei Xu, Dan Liao, Jing Zhang, Lin‐Feng Chen et al. · 2026 · Journal of Neurochemistry
  41. Structure‐Guided Identification of Peptide Therapeutics Targeting BACE1 for Alzheimer's Disease Through Energy Profiling and Multivariate Analysis
    Kavita Patel, Ashutosh Mani · 2026 · ChemistrySelect
  42. Tau Protein in Alzheimer's Disease
    Maitreyee Mukherjee, Soumen Dhara, Abhishek Jana, Tathagata Roy · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
  43. Targeting the pathological tau N368 fragment: A pharmacological perspective on a novel immunotherapy for Alzheimer’s disease
    Zhengjiang Qian, Zhengtao Hu, Y C Li, Daqiang Zuo, Ruikun He, Keqiang Ye · 2026 · Pharmacological Research
  44. Protease-Mediated TAR DNA-Binding Protein 43 (TDP-43) Pathogenesis: From Molecular Mechanisms to Therapeutic Opportunities
    Joyal Xavier, Meenakshi Singh, Sampada P Tamhankar, Kristine Griffett, Rajesh Amin · 2026 · ACS Pharmacology & Translational Science
  45. Endothelial C/EBPβ/AEP pathway drives vascular deterioration and systemic aging
    Bowei Li, Shuke Nie, Mengmeng Wang, Jiawei An, Zhengjiang Qian, Xin Meng, Laura E. Edgington‐Mitchell, Zhentao Zhang, Xifei Yang, Keqiang Ye · 2026 · Science Advances
  46. BindingDB Entry 50012737: High-Throughput Screening for the Discovery of Enzyme Inhibitors.
    BindingDB · 2022 · UC San Diego
  47. BindingDB Entry 50017218: Modular synthesis of 2,4-diaminoanilines as CNS drug-like non-covalent inhibitors of asparagine endopeptidase.
    BindingDB · 2023 · UC San Diego
  48. BindingDB Entry 50020585: Discovery of Orally Available and Brain Penetrant AEP Inhibitors.
    BindingDB · 2024 · UC San Diego
  49. BindingDB Entry 50000127: Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis.
    BindingDB · 2019 · UC San Diego